Menu
Back to Journals » Clinical Ophthalmology » Volume 2 » Issue 4
Original Research
Intravitreal bevacizumab has initial clinical benefit lasting eight weeks in eyes with neovascular age-related macular degeneration
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,533 | Dovepress* | 5,533+ | 1,673 | 7,206 | |
| Totals | 5,533 | 1,673 | 7,206 | ||
|
*Since 5 December 2008 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 1 |
View citations on Google Scholar